These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 2683424)

  • 1. [In vivo effects of high density lipoprotein rich serum fractions (HDLF) in the human. 2. Effect of repeated HDLF infusions on atherogenic risk factors and arteriosclerotic vascular changes in patients with and without hyperlipoproteinemia].
    Kuklinski B; Parfionov AS; Rühlmann C; Zimmermann R; Herrmann W; Richter V; Köhler H; Grossmann KD; Peters HJ; Duck HJ
    Z Gesamte Inn Med; 1989 Jul; 44(14):421-6. PubMed ID: 2683424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [In vivo effects of high density lipoprotein rich serum fractions (HDLF) in the human. 1. Modification of circulating thrombocyte aggregates, cardiovascular parameters and lipid metabolism by HDLF].
    Kuklinski B; Parfionov AS; Zimmermann R; Rühlmann C; Köhler H; Reuter W; Herrmann W; Grossmann KD; Appelt D; Arnold R
    Z Gesamte Inn Med; 1989 Jul; 44(14):413-20. PubMed ID: 2683423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [High-density lipoprotein cholesterol and the atherogenic index in patients with different types of hyperlipoproteinemias].
    Apostolov I; Naumova R; Balabanski L; Goranov I
    Vutr Boles; 1983; 22(3):70-4. PubMed ID: 6649586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arteriovenous lipid content difference in patients with atherosclerosis.
    Ivaniv YuA
    Cor Vasa; 1985; 27(4):304-9. PubMed ID: 4053621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The relation between lipoprotein fractions, sex and IHD in patients with primary hyperlipoproteinemia].
    Hora C; Hanefeld M; Leonhardt W; Jacob F; Haller H
    Z Gesamte Inn Med; 1982 Dec; 37(23):801-4. PubMed ID: 7164523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in the concentration and composition of lipids and lipoproteins in primary hyperlipoproteinemia during treatment with bezafibrate.
    Hutt V; Wechsler JG; Klör HU; Ditschuneit H
    Arzneimittelforschung; 1983; 33(8):1185-90. PubMed ID: 6685498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The new atherogenic plasma index reflects the triglyceride and HDL-cholesterol ratio, the lipoprotein particle size and the cholesterol esterification rate: changes during lipanor therapy].
    Dobiásová M; Frohlich J
    Vnitr Lek; 2000 Mar; 46(3):152-6. PubMed ID: 11048517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reconstituted high-density lipoprotein increases plasma high-density lipoprotein anti-inflammatory properties and cholesterol efflux capacity in patients with type 2 diabetes.
    Patel S; Drew BG; Nakhla S; Duffy SJ; Murphy AJ; Barter PJ; Rye KA; Chin-Dusting J; Hoang A; Sviridov D; Celermajer DS; Kingwell BA
    J Am Coll Cardiol; 2009 Mar; 53(11):962-71. PubMed ID: 19281927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of a clofibrate-inositol nicotinate combination on lipids and lipoproteins in primary hyperlipoproteinemia of types IIa, IV and V].
    Hutt V; Wechsler JG; Klör HU; Ditschuneit H
    Arzneimittelforschung; 1983; 33(5):776-9. PubMed ID: 6683558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical significance of arteriosclerosis indices of lipid metabolism and age dependence].
    Reuter W; Herrmann W; Voigt H; Köhler H; Schütz C; Hanf S; Lindhofer HG; Kuklinski B
    Z Alternsforsch; 1983; 38(5):361-7. PubMed ID: 6659565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Evaluation of apoproteins A and B, lipoproteins and plasma lipids during treatment with bezafibrate in various forms of hyperlipoproteinemia].
    Saitta A; Bonaiuto M; Lanzafame F; Mileto A; Pernice F; Cinquegrani M; Mazza G; Micali G; Pangallo A; Fodale P
    Clin Ter; 1988 Mar; 124(5):373-81. PubMed ID: 2974348
    [No Abstract]   [Full Text] [Related]  

  • 12. [Fatty acid composition of phosphatidylcholine and levels of lipids and lipoproteins in hyperlipoproteinemia. I. Relation to HDL lipoprotein].
    Zák A; Zeman M; Tvrzická E
    Cas Lek Cesk; 1998 Jun; 137(12):368-71. PubMed ID: 9721473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A 52-week, randomized, open-label, parallel-group comparison of the tolerability and effects of pitavastatin and atorvastatin on high-density lipoprotein cholesterol levels and glucose metabolism in Japanese patients with elevated levels of low-density lipoprotein cholesterol and glucose intolerance.
    Sasaki J; Ikeda Y; Kuribayashi T; Kajiwara K; Biro S; Yamamoto K; Ageta M; Kobori S; Saikawa T; Otonari T; Kono S
    Clin Ther; 2008 Jun; 30(6):1089-101. PubMed ID: 18640465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemorrheologic abnormalities in defined primary dyslipoproteinemias with both high and low atherosclerotic risks.
    Otto C; Ritter MM; Richter WO; Minkenberg R; Schwandt P
    Metabolism; 2001 Feb; 50(2):166-70. PubMed ID: 11229424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of 1 month's treatment with Bezalip on the serum lipids and lipoproteins of patients with different types of hyperlipoproteinemias].
    Kiriakov A; Malamov E; Apostolova Iu; Tsenov I; Tinterova Z
    Vutr Boles; 1983; 22(3):74-81. PubMed ID: 6649587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduction of low density and high density lipoprotein cholesterol by fat-modified diets. A survey of recent findings.
    Vessby B; Lithell H; Boberg J
    Hum Nutr Clin Nutr; 1982; 36(3):203-11. PubMed ID: 6749766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Initial experiences with the effect of chronic intermittent electromyostimulation in patients with hyperlipoproteinemias and arterial circulatory disorders].
    Kuklinski B; Gibas P; Köhler H; Grossmann KD; Rühlmann C; Zimmermann R; Voigt H; Reuter W; Duck HJ; Bühnert G
    Z Gesamte Inn Med; 1988 Jan; 43(1):6-11. PubMed ID: 3258458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High density lipoprotein and arteriosclerosis. Different patterns in primary hypothyroidism and type IIa hyperlipoproteinemia.
    Brook JG; Aviram M; Luboshitzky R; Barzilai D
    Isr J Med Sci; 1981 May; 17(5):318-22. PubMed ID: 7263188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cholesterol bound to high density lipoproteins: critical review of the methods of analysis and personal data].
    Orso Giacone G
    Ann Osp Maria Vittoria Torino; 1982; 24(7-12):286-306. PubMed ID: 7137764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Composition of VLDL, LDL and HDL lipoprotein fractions in type IIa, IIb, III, IV, and V hyperlipemia patients in comparison with healthy individuals].
    Hutt V; Klör HU; Wechsler JG; Ditschuneit H
    J Clin Chem Clin Biochem; 1984 Feb; 22(2):141-6. PubMed ID: 6716054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.